Last Updated: May 11, 2026

Suppliers and packagers for NORETHINDRONE AND ETHINYL ESTRADIOL


✉ Email this page to a colleague

« Back to Dashboard


NORETHINDRONE AND ETHINYL ESTRADIOL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Naari Pte NORETHINDRONE AND ETHINYL ESTRADIOL ethinyl estradiol; norethindrone TABLET;ORAL-28 206864 ANDA Naari Pte Limited 79929-007-07 3 BLISTER PACK in 1 CARTON (79929-007-07) / 1 KIT in 1 BLISTER PACK 2022-12-31
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Norethindrone and Ethinyl Estradiol Suppliers: Global Market Analysis

Last updated: February 19, 2026

This report analyzes the global supply landscape for Norethindrone and Ethinyl Estradiol, active pharmaceutical ingredients (APIs) central to many oral contraceptive and hormone replacement therapies. The market is characterized by a concentrated number of manufacturers, with a significant portion of production located in Asia. Key supply chain considerations include regulatory compliance, batch consistency, and potential for geopolitical disruption.

Who are the Primary Manufacturers of Norethindrone API?

The manufacturing of Norethindrone API is concentrated among a limited number of global suppliers. These entities are critical for the production of a wide range of pharmaceutical products.

  • Teva Pharmaceutical Industries Ltd.: A major player in API manufacturing, Teva produces Norethindrone. The company operates production facilities globally, adhering to strict regulatory standards. [1]
  • Sun Pharmaceutical Industries Ltd.: This Indian multinational is a significant producer of APIs, including Norethindrone. Sun Pharma's manufacturing capabilities support its broad generic drug portfolio. [2]
  • Ipsen Pharma S.A.S.: While known for its finished drug products, Ipsen also engages in API manufacturing, including Norethindrone, often for internal use and strategic partnerships. [3]
  • Core Pharma LLC: This company is involved in the development and manufacturing of generic pharmaceuticals and APIs, with Norethindrone being a product in its catalog. [4]
  • Anchem Laboratories Ltd.: Anchem manufactures various APIs, including Norethindrone, supplying to the pharmaceutical industry. [5]

Table 1: Selected Norethindrone API Manufacturers

Manufacturer Primary Region of Operation Key Product Focus (API)
Teva Pharmaceutical Industries Ltd. Global Norethindrone
Sun Pharmaceutical Industries Ltd. India Norethindrone
Ipsen Pharma S.A.S. Europe Norethindrone
Core Pharma LLC North America Norethindrone
Anchem Laboratories Ltd. Asia Norethindrone

Which Companies Supply Ethinyl Estradiol API?

Ethinyl Estradiol, another crucial steroid hormone, is manufactured by a comparable set of global API producers, often overlapping with Norethindrone suppliers.

  • BASF SE: A leading chemical producer, BASF is a significant supplier of Ethinyl Estradiol API. Its extensive chemical synthesis expertise underpins its pharmaceutical ingredient production. [6]
  • Amneal Pharmaceuticals LLC: Amneal is a prominent generic pharmaceutical company with substantial API manufacturing operations. Ethinyl Estradiol is part of its API portfolio. [7]
  • Xinhua Pharmaceutical (Group) Co., Ltd.: Based in China, Xinhua Pharmaceutical is a large-scale manufacturer of APIs, including Ethinyl Estradiol, serving both domestic and international markets. [8]
  • Fagron Group: Fagron is a global pharmaceutical compounding company that also sources and supplies APIs, including Ethinyl Estradiol, to pharmacies and pharmaceutical manufacturers. [9]
  • Centrient Pharmaceuticals: This company produces a range of APIs, and Ethinyl Estradiol is among its offerings, supporting the global pharmaceutical supply chain. [10]

Table 2: Selected Ethinyl Estradiol API Manufacturers

Manufacturer Primary Region of Operation Key Product Focus (API)
BASF SE Germany Ethinyl Estradiol
Amneal Pharmaceuticals LLC North America Ethinyl Estradiol
Xinhua Pharmaceutical Group China Ethinyl Estradiol
Fagron Group Global Ethinyl Estradiol (Sourcing/Supply)
Centrient Pharmaceuticals Global Ethinyl Estradiol

What are the Regulatory Requirements for API Manufacturing of these Compounds?

Manufacturers of Norethindrone and Ethinyl Estradiol API must adhere to stringent global regulatory frameworks to ensure product safety, efficacy, and quality. Key requirements include:

  • Good Manufacturing Practices (GMP): Compliance with GMP standards, as defined by regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO), is mandatory. This covers all aspects of production, from raw material sourcing to finished API testing.
  • Drug Master Files (DMFs): Manufacturers typically submit DMFs to regulatory agencies. These confidential documents contain detailed information about the manufacturing process, facilities, and controls for the API. Pharmaceutical companies using the API reference these DMFs in their drug product applications.
  • Impurity Profiling: Rigorous testing and control of impurities are essential. Regulatory guidelines, such as those from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), set limits for process-related impurities and degradation products. [11]
  • Stability Testing: API manufacturers must conduct comprehensive stability studies to determine the shelf-life and recommended storage conditions for Norethindrone and Ethinyl Estradiol. This data supports the API's suitability for inclusion in finished pharmaceutical products.
  • Site Inspections and Audits: Manufacturing facilities are subject to regular inspections by regulatory authorities and audits by pharmaceutical companies that purchase the APIs. These assessments verify ongoing compliance with GMP and other relevant regulations.
  • REACH Compliance (Europe): For APIs sold within the European Union, compliance with the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation is necessary for the chemical substances themselves, beyond their pharmaceutical application. [12]

What is the Geographic Concentration of API Production?

The production of Norethindrone and Ethinyl Estradiol APIs exhibits a significant geographic concentration, primarily in Asia, with India and China being dominant manufacturing hubs.

  • India: A substantial percentage of global API production, including steroid hormones like Norethindrone and Ethinyl Estradiol, originates from India. The country has a well-established pharmaceutical industry, skilled workforce, and cost-effective manufacturing infrastructure. [2]
  • China: China is another major global supplier of APIs. Its large-scale chemical synthesis capabilities and extensive manufacturing network position it as a key source for these compounds. [8]
  • Europe: While less concentrated than Asia, some European countries, particularly Germany and France, host manufacturers like BASF and Ipsen that produce these APIs, often focusing on high-value or specialized production. [3, 6]
  • North America: The United States and Canada have API manufacturers, such as Amneal and Core Pharma, that contribute to the supply, though often at a smaller scale compared to Asian giants. [4, 7]

This concentration presents both opportunities and risks. It allows for economies of scale and competitive pricing but also introduces potential vulnerabilities related to geopolitical stability, trade policies, and supply chain disruptions.

Figure 1: Estimated Global API Production Share for Norethindrone and Ethinyl Estradiol

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.